Hemming, Pierre
Kaur, Rajneesh http://orcid.org/0000-0002-4406-4327
Meiser, Bettina http://orcid.org/0000-0002-5086-0784
McKinley, Joanne http://orcid.org/0000-0001-5572-0177
Young, Mary-Anne http://orcid.org/0000-0002-2493-6394
James, Paul A. http://orcid.org/0000-0002-4361-4657
Forrest, Laura E. http://orcid.org/0000-0002-1126-4971
Funding for this research was provided by:
National Health and Medical Research Council (http://purl.org/au-research/grants/nhmrc/1092856, ID 1078523)
National Breast Cancer Foundation (PF-14-009)
Article History
Received: 23 September 2020
Accepted: 20 April 2021
First Online: 6 May 2021
Declarations
: This study was approved by the Peter MacCallum Human Research Ethics Committee, Victoria, Australia (protocol no. 17/16). Verbal consent was obtained prior to audio-recording each interview. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
: Paul James is the director of the Parkville Familial Cancer Centre at the Peter MacCallum Cancer Centre that received funding from AstraZeneca for the Telephone Genetic Counseling Service. Bettina Meiser has a remunerated consultant role with the company AstraZeneca with respect to an unrelated project. Laura Forrest, Joanne McKinley, Rajneesh Kaur, Mary-Anne Young, and Pierre Hemming declare that they have no conflict of interest.